{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:17:23Z","timestamp":1773933443349,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH K12 HD028820-27"],"award-info":[{"award-number":["NIH K12 HD028820-27"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00467-020-04541-3","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T10:33:43Z","timestamp":1589884423000},"page":"1887-1896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse"],"prefix":"10.1007","volume":"35","author":[{"given":"Gabriel","family":"Cara-Fuentes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhusudan","family":"Venkatareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfons","family":"Segarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey C.","family":"Cleuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Mart\u00ednez-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneet","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"issue":"3","key":"4541_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2215\/CJN.04121206","volume":"2","author":"L Barisoni","year":"2007","unstructured":"Barisoni L, Schnaper HW, Kopp JB (2007) A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. CJASN 2(3):529\u2013542","journal-title":"CJASN"},{"issue":"2","key":"4541_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F (2017) Minimal change disease. CJASN 12(2):332\u2013345. https:\/\/doi.org\/10.2215\/CJN.05000516","journal-title":"CJASN"},{"issue":"4","key":"4541_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00467-017-3677-5","volume":"33","author":"M Colucci","year":"2018","unstructured":"Colucci M, Corpetti G, Emma F, Vivarelli M (2018) Immunology of idiopathic nephrotic syndrome. Pediatr Nephrol 33(4):573\u2013584. https:\/\/doi.org\/10.1007\/s00467-017-3677-5","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"4541_CR4","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe AH, Kreidberg JA, Mundel P (2004) Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113(10):1390\u20131397","journal-title":"J Clin Invest"},{"issue":"6","key":"4541_CR5","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/ndt\/gfs543","volume":"28","author":"T Ishimoto","year":"2013","unstructured":"Ishimoto T, Shimada M, Gabriela G, Kosugi T, Sato W, Lee PY, Lanaspa MA, Rivard C, Maruyama S, Garin EH, Johnson RJ (2013) Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice. Nephrol Dial Transplant 28(6):1439\u20131446. https:\/\/doi.org\/10.1093\/ndt\/gfs543","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"4541_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1242\/dmm.023440","volume":"9","author":"N Jain","year":"2016","unstructured":"Jain N, Khullar B, Oswal N, Banoth B, Joshi P, Ravindran B, Panda S, Basak S, George A, Rath S, Bal V, Sopory S (2016) TLR-mediated albuminuria needs TNFalpha-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice. Dis Model Mech 9(6):707\u2013717. https:\/\/doi.org\/10.1242\/dmm.023440","journal-title":"Dis Model Mech"},{"issue":"10","key":"4541_CR7","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/tri.13273","volume":"31","author":"CJ Rivard","year":"2018","unstructured":"Rivard CJ, Tanabe T, Lanaspa MA, Watanabe H, Nomura S, Andres-Hernando A, Garth K, Sekijima M, Ishimoto T, Ariyoshi Y, Garcia GE, Shah J, Lennan B, Tasaki M, Pomposelli T, Shimizu A, Sachs DH, Johnson RJ, Yamada K (2018) Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study. Transpl Int 31(10):1164\u20131177. https:\/\/doi.org\/10.1111\/tri.13273","journal-title":"Transpl Int"},{"issue":"1","key":"4541_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/ndt\/gfr271","volume":"27","author":"M Shimada","year":"2012","unstructured":"Shimada M, Ishimoto T, Lee PY, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Wymer DT, Yamabe H, Mathieson PW, Saleem MA, Garin EH, Johnson RJ (2012) Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-kappaB-dependent pathway. Nephrol Dial Transplant 27(1):81\u201389. https:\/\/doi.org\/10.1093\/ndt\/gfr271","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"4541_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/path.4235","volume":"231","author":"S Gurkan","year":"2013","unstructured":"Gurkan S, Cabinian A, Lopez V, Bhaumik M, Chang JM, Rabson AB, Mundel P (2013) Inhibition of type I interferon signalling prevents TLR ligand-mediated proteinuria. J Pathol 231(2):248\u2013256","journal-title":"J Pathol"},{"issue":"25","key":"4541_CR10","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"CC Yu","year":"2013","unstructured":"Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang JM, Chen HC, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW 3rd, Mundel P (2013) Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 369(25):2416\u20132423. https:\/\/doi.org\/10.1056\/NEJMoa1304572","journal-title":"N Engl J Med"},{"issue":"2","key":"4541_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1681\/ASN.2007080836","volume":"20","author":"EH Garin","year":"2009","unstructured":"Garin EH, Diaz LN, Mu W, Wasserfall C, Araya C, Segal M, Johnson RJ (2009) Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 20(2):260\u2013266. https:\/\/doi.org\/10.1681\/ASN.2007080836","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"4541_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ki.2010.143","volume":"78","author":"EH Garin","year":"2010","unstructured":"Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ (2010) Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 78(3):296\u2013302. https:\/\/doi.org\/10.1038\/ki.2010.143","journal-title":"Kidney Int"},{"issue":"8","key":"4541_CR13","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00467-013-2679-1","volume":"29","author":"G Cara-Fuentes","year":"2014","unstructured":"Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH (2014) CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol 29(8):1363\u20131371. https:\/\/doi.org\/10.1007\/s00467-013-2679-1","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"4541_CR14","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s00467-014-2874-8","volume":"29","author":"G Cara-Fuentes","year":"2014","unstructured":"Cara-Fuentes G, Wasserfall CH, Wang H, Johnson RJ, Garin EH (2014) Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis? Pediatr Nephrol 29(12):2333\u20132340. https:\/\/doi.org\/10.1007\/s00467-014-2874-8","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"4541_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00467-014-2915-3","volume":"30","author":"C Ling","year":"2015","unstructured":"Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q (2015) Urinary CD80 levels as a diagnostic biomarker of minimal change disease. Pediatr Nephrol 30(2):309\u2013316. https:\/\/doi.org\/10.1007\/s00467-014-2915-3","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"4541_CR16","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00467-017-3613-8","volume":"32","author":"OP Mishra","year":"2017","unstructured":"Mishra OP, Kumar R, Narayan G, Srivastava P, Abhinay A, Prasad R, Singh A, Batra VV (2017) Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome. Pediatr Nephrol 32(8):1355\u20131361. https:\/\/doi.org\/10.1007\/s00467-017-3613-8","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"4541_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41390-018-0088-7","volume":"84","author":"D Bhatia","year":"2018","unstructured":"Bhatia D, Sinha A, Hari P, Sopory S, Saini S, Puraswani M, Saini H, Mitra DK, Bagga A (2018) Rituximab modulates T- and B-lymphocyte subsets and urinary CD80 excretion in patients with steroid-dependent nephrotic syndrome. Pediatr Res 84(4):520\u2013526. https:\/\/doi.org\/10.1038\/s41390-018-0088-7","journal-title":"Pediatr Res"},{"issue":"7","key":"4541_CR18","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s00467-018-3885-7","volume":"33","author":"C Ling","year":"2018","unstructured":"Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q (2018) Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome. Pediatr Nephrol 33(7):1183\u20131187. https:\/\/doi.org\/10.1007\/s00467-018-3885-7","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"4541_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00467-014-2957-6","volume":"30","author":"EH Garin","year":"2015","unstructured":"Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ (2015) Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol 30(3):469\u2013477. https:\/\/doi.org\/10.1007\/s00467-014-2957-6","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"4541_CR20","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.ekir.2019.05.1155","volume":"4","author":"R Isom","year":"2019","unstructured":"Isom R, Shoor S, Higgins J, Cara-Fuentes G, Johnson RJ (2019) Abatacept in steroid-dependent minimal change disease and CD80-uria. Kidney Int Rep 4(9):1349\u20131353. https:\/\/doi.org\/10.1016\/j.ekir.2019.05.1155","journal-title":"Kidney Int Rep"},{"issue":"6","key":"4541_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1053\/j.ajkd.2014.07.023","volume":"64","author":"CP Larsen","year":"2014","unstructured":"Larsen CP, Messias NC, Walker PD (2014) B7-1 immunostaining in proteinuric kidney disease. Am J Kidney Dis 64(6):1001\u20131003. https:\/\/doi.org\/10.1053\/j.ajkd.2014.07.023","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"4541_CR22","doi-asserted-by":"publisher","first-page":"F335","DOI":"10.1152\/ajprenal.00510.2015","volume":"310","author":"R Novelli","year":"2016","unstructured":"Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G (2016) Any value of podocyte B7-1 as a biomarker in human MCD and FSGS? Am J Physiol Renal Physiol 310(5):F335\u2013F341. https:\/\/doi.org\/10.1152\/ajprenal.00510.2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"4541_CR23","doi-asserted-by":"publisher","first-page":"41859","DOI":"10.1038\/srep41859","volume":"7","author":"SW Lee","year":"2017","unstructured":"Lee SW, Baek SH, Paik JH, Kim S, Na KY, Chae DW, Chin HJ (2017) Tubular B7-1 expression parallels proteinuria levels, but not clinical outcomes in adult minimal change disease patients. Sci Rep 7:41859. https:\/\/doi.org\/10.1038\/srep41859","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"4541_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1440-1754.2004.00285.x","volume":"40","author":"RK Alwadhi","year":"2004","unstructured":"Alwadhi RK, Mathew JL, Rath B (2004) Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection. J Pediatr Child Health 40(1\u20132):28\u201332","journal-title":"J Pediatr Child Health"},{"issue":"47","key":"4541_CR25","doi-asserted-by":"publisher","first-page":"23618","DOI":"10.1073\/pnas.1912409116","volume":"116","author":"ACA Cleuren","year":"2019","unstructured":"Cleuren ACA, van der Ent MA, Jiang H, Hunker KL, Yee A, Siemieniak DR, Molema G, Aird WC, Ganesh SK, Ginsburg D (2019) The in vivo endothelial cell translatome is highly heterogeneous across vascular beds. Proc Natl Acad Sci U S A 116(47):23618\u201323624. https:\/\/doi.org\/10.1073\/pnas.1912409116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4541_CR26","doi-asserted-by":"publisher","first-page":"17322","DOI":"10.1038\/s41598-018-35798-227","volume":"8","author":"S Minamikawa","year":"2018","unstructured":"Minamikawa S, Nozu K, Maeta S, Yamamura T, Nakanishi K, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Nagase H, Shima H, Noda K, Ninchoji T, Kaito H, Iijima K (2018) The utility of urinary CD80 as a diagnostic marker in patients with renal diseases. Sci Rep 8(1):17322. https:\/\/doi.org\/10.1038\/s41598-018-35798-227","journal-title":"Sci Rep"},{"issue":"51","key":"4541_CR27","doi-asserted-by":"publisher","first-page":"88332","DOI":"10.18632\/oncotarget.19917","volume":"8","author":"P Wang","year":"2017","unstructured":"Wang P, Zhou S, Ge Y, Lu M, Liu Z, Gong R (2017) Valproate hampers podocyte acquisition of immune phenotypes via intercepting the GSK3beta facilitated NFkB activation. Oncotarget 8(51):88332\u201388344. https:\/\/doi.org\/10.18632\/oncotarget.19917","journal-title":"Oncotarget"},{"issue":"5","key":"4541_CR28","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.kint.2016.06.022","volume":"90","author":"E Baye","year":"2016","unstructured":"Baye E, Gallazzini M, Delville M, Legendre C, Terzi F, Canaud G (2016) The costimulatory receptor B7-1 is not induced in injured podocytes. Kidney Int 90(5):1037\u20131044. https:\/\/doi.org\/10.1016\/j.kint.2016.06.022","journal-title":"Kidney Int"},{"key":"4541_CR29","doi-asserted-by":"publisher","unstructured":"Chen W, Wu Y, Zhang G, Wang M, Yang H, Li Q (2018) GammadeltaT cells exacerbate podocyte injury via the CD28\/B7-1-phosphor-SRC kinase pathway. Biomed Res Int:5647120. https:\/\/doi.org\/10.1155\/2018\/5647120","DOI":"10.1155\/2018\/5647120"},{"issue":"3","key":"4541_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s10157-017-1489-3","volume":"22","author":"B Khullar","year":"2018","unstructured":"Khullar B, Balyan R, Oswal N, Jain N, Sharma A, Abdin MZ, Bagga A, Bhatnagar S, Wadhwa N, Natchu UCM, George A, Rath S, Bal V, Sopory S (2018) Interaction of CD80 with Neph1: a potential mechanism of podocyte injury. Clin Exp Nephrol 22(3):508\u2013516. https:\/\/doi.org\/10.1007\/s10157-017-1489-3","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"4541_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0022-3476(86)80876-9","volume":"108","author":"NE MacDonald","year":"1986","unstructured":"MacDonald NE, Wolfish N, McLaine P, Phipps P, Rossier E (1986) Role of respiratory viruses in exacerbations of primary nephrotic syndrome. J Pediatr 108(3):378\u2013382","journal-title":"J Pediatr"},{"issue":"2","key":"4541_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000110088","volume":"28","author":"M Tkaczyk","year":"2008","unstructured":"Tkaczyk M, Czupryniak A, Owczarek D, Lukamowicz J, Nowicki M (2008) Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome. Am J Nephrol 28(2):197\u2013202","journal-title":"Am J Nephrol"},{"issue":"2","key":"4541_CR33","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.atherosclerosis.2014.01.055","volume":"233","author":"B Sharma","year":"2014","unstructured":"Sharma B, Saha A, Dubey NK, Kapoor K, Anubhuti BVV, Upadhayay AD (2014) Endothelial dysfuntion in children with idiopathic nephrotic syndrome. Atherosclerosis 233(2):704\u2013706. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.01.055","journal-title":"Atherosclerosis"},{"key":"4541_CR34","doi-asserted-by":"publisher","unstructured":"Chaves MMS, Mendes MS, Schwermann MP, Queiroz R, Coelho RF, Salmito FTS, Meneses GC, Martins AMC, Moreira ACOM, Lib\u00f3rio AB (2018) Angiopoietin-2: a potential mediator of the glycocalyx injury in adult nephrotic patients. J Clin Med 7(11). https:\/\/doi.org\/10.3390\/jcm7110401","DOI":"10.3390\/jcm7110401"},{"issue":"6","key":"4541_CR35","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1053\/j.ajkd.2014.01.427","volume":"63","author":"K Ohl","year":"2014","unstructured":"Ohl K, Eberhardt C, Spink C, Zahn K, Wagner N, Eggermann T, Kemper MJ, Querfeld U, Hoppe B, Harendza S, Tenbrock K (2014) CTLA4 polymorphisms in minimal change nephrotic syndrome in children: a case-control study. Am J Kidney Dis 63(6):1074\u20131075. https:\/\/doi.org\/10.1053\/j.ajkd.2014.01.427","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"4541_CR36","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00467-010-1507-0","volume":"25","author":"K Benz","year":"2010","unstructured":"Benz K, Buttner M, Dittrich K, Campean V, Dotsch J, Amann K (2010) Characterisation of renal immune cell infiltrates in children with nephrotic syndrome. Pediatr Nephrol 25(7):1291\u20131298. https:\/\/doi.org\/10.1007\/s00467-010-1507-0","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"4541_CR37","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/ki.2008.19","volume":"73","author":"K Uchida","year":"2008","unstructured":"Uchida K, Suzuki K, Iwamoto M, Kawachi H, Ohno M, Horita S, Nitta K (2008) Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis. Kidney Int 73(8):926\u2013932. https:\/\/doi.org\/10.1038\/ki.2008.19","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04541-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T23:59:43Z","timestamp":1620777583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04541-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4541"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04541-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"4 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}